Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 18.05.2026 1 Alzheimer Dis Assoc Disord 10 Alzheimers Dement 2 Am J Alzheimers Dis Other Demen 1 Ann Neurol 1 Brain Res 2 Exp Neurol 7 J Alzheimers Dis 1 J Neural Transm (Vienna) 2 J Neurochem 1 J Neurol 2 Lancet Neurol 5 Neurobiol Aging 1 Neurobiol Dis 1 Neurochem Res 1 Neurol Clin Pract 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimer Dis Assoc Disord

1. MORI-FEGAN DK, Wong YY, Noor S, Wu CY, et al
   Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer Disease.
   Alzheimer Dis Assoc Disord. 2026 May 13. doi: 10.1097/WAD.0000000000000723.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

2. STARK M, Wagner M, Kuhn E, Roeske S, et al
   Minor neuropsychological deficits and stage 2 of Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71458.
   PubMed         Abstract available
   
   
3. LIU Z, Che C, He G, Wu H, et al
   Mandarin speech-based early detection of SCD: a feature-fusion residual network method.
   Alzheimers Dement. 2026;22:e71460.
   PubMed         Abstract available
   
   
4. HOANG MT, Kahn JG, Saha S, Trepel D, et al
   Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis.
   Alzheimers Dement. 2026;22:e71308.
   PubMed         Abstract available
   
   
5. KOLLING LJ, Balasubramanian N, Ismail S, Feller AJ, et al
   Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71317.
   PubMed         Abstract available
   
   
6. FU Q, Yin X, Xu S
   Disentangling treatment status from disease severity in studies of diabetes and Alzheimer's disease biomarkers.
   Alzheimers Dement. 2026;22:e71465.
   PubMed        
   
   
7. CHAN CK, Lane KA, Gao S, Adeoye-Olatunde OA, et al
   Technology access and preferences for remote assessments at Alzheimer's Disease Research Centers.
   Alzheimers Dement. 2026;22:e71467.
   PubMed         Abstract available
   
   
8. YU G, Thorpe A, Zeng Q, Wang E, et al
   Single-cell transcriptomic analysis reveals APOE genotype-dependent sex differences in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71463.
   PubMed         Abstract available
   
   
9. FRIJO A, Mazzeo S, Filippi M, Salsone M, et al
   Rethinking Alzheimer's disease susceptibility and heterogeneity. Comment on Miller et al.
   Alzheimers Dement. 2026;22:e71456.
   PubMed        
   
   
10. MILLER ZA, Miller BL, Rabinovici GD, Gorno-Tempini ML, et al
    Response to rethinking Alzheimer's disease susceptibility and heterogeneity. Comment on Miller et al.
    Alzheimers Dement. 2026;22:e71454.
    PubMed        
    
    
11. CHAO Y, Chen Y, Chadwick TA, Harrison TM, et al
    Correlation between in vivo (18)F-flortaucipir PET and whole-brain postmortem histological tau signals in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71453.
    PubMed         Abstract available
    
    

    
    Am J Alzheimers Dis Other Demen

12. JUNI JE, Burns JM, Salat DH, Hill D, et al
    Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial.
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261451918.
    PubMed         Abstract available
    
    
13. JUDAY TR, Holub A, Mattke S, Betts KA, et al
    Community-Based Physician Attitudes Related to the Diagnosis and Treatment of Early Alzheimer's Disease in the United States.
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261433309.
    PubMed         Abstract available
    
    

    
    Ann Neurol

14. KASPER E, Lehto A, Jurs A, Nordmann N, et al
    Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.
    Ann Neurol. 2026 May 11. doi: 10.1002/ana.78227.
    PubMed         Abstract available
    
    

    
    Brain Res

15. LI Y, Chen J
    Lentinan attenuates tau phosphorylation and memory deficits in hTau-overexpressing mice.
    Brain Res. 2026;1885:150340.
    PubMed         Abstract available
    
    

    
    Exp Neurol

16. KHATTAB NA, El Kadeem A, Goda AE, El-Mahdy NA, et al
    Aluminum chloride in Alzheimer's disease: A dual focus on molecular mechanisms and rat experimental models.
    Exp Neurol. 2026;403:115814.
    PubMed         Abstract available
    
    
17. MARTINEZ-DRUDIS L, Sheta R, Musiol D, Teixeira M, et al
    The emerging role of polo-like kinase 2 in Alzheimer's disease.
    Exp Neurol. 2026;403:115806.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

18. HAO X, Jiao B, Wang Y, Xu T, et al
    Association of mitochondrial genome variants with Alzheimer's disease in a Chinese population.
    J Alzheimers Dis. 2026 May 8:13872877261442231. doi: 10.1177/13872877261442231.
    PubMed         Abstract available
    
    
19. TANG Q, Liu J, Fan C, Zhang X, et al
    Early diagnosis of Alzheimer's disease through handwriting analysis and deep learning: A review.
    J Alzheimers Dis. 2026 May 9:13872877261446573. doi: 10.1177/13872877261446573.
    PubMed         Abstract available
    
    
20. IGARASHI A, Azuma-Kasai M, Tani M, Utsumi T, et al
    The social value of lecanemab for patients with early Alzheimer's disease in Japan.
    J Alzheimers Dis. 2026 May 10:13872877261447312. doi: 10.1177/13872877261447312.
    PubMed         Abstract available
    
    
21. BENDER O, Shemesh OA, Bar DZ
    Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease.
    J Alzheimers Dis. 2026 May 11:13872877261447530. doi: 10.1177/13872877261447530.
    PubMed         Abstract available
    
    
22. FRATTO E, Buonocore J, Fortunato F, Sammarra I, et al
    The bidirectional association of epilepsy with Alzheimer's disease and other neurodegenerative dementias: A longitudinal observational study on the UK Biobank.
    J Alzheimers Dis. 2026 May 14:13872877261450962. doi: 10.1177/13872877261450962.
    PubMed         Abstract available
    
    
23. AHMED HM, Ali Siddique M, Shaheer Ul Islam M, Khan Lodhi AR, et al
    Systemic interleukin signaling and Alzheimer's disease risk: A two-sample cross-replication Mendelian randomization study.
    J Alzheimers Dis. 2026 May 11:13872877261449516. doi: 10.1177/13872877261449516.
    PubMed         Abstract available
    
    
24. SENOL D, Secgin Y, Kaya S, Ozturk O, et al
    Comparison of hippocampus, entorhinal cortex, and amygdala volumes in individuals with Alzheimer's disease, mild cognitive impairment, and healthy individuals.
    J Alzheimers Dis. 2026 May 11:13872877261450574. doi: 10.1177/13872877261450574.
    PubMed         Abstract available
    
    

    
    J Neural Transm (Vienna)

25. SODAEI F, Vafaee MS, Michel TM, Rad HS, et al
    From MRI to 3D printing: a tangible neuroeducational tool for visualizing hippocampal morphology and Alzheimer's disease progression.
    J Neural Transm (Vienna). 2026 May 14. doi: 10.1007/s00702-026-03130.
    PubMed         Abstract available
    
    

    
    J Neurochem

26. SHARMIN T, Doecke JD, Chatterjee P, Pedrini S, et al
    Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.
    J Neurochem. 2026;170:e70436.
    PubMed         Abstract available
    
    
27. WEBB-ROBINSON C, Murray H, Turner CP, Palpagama T, et al
    Insulin Receptor Isoform Pattern in Aged Normal and Alzheimer's Human Cortex.
    J Neurochem. 2026;170:e70455.
    PubMed         Abstract available
    
    

    
    J Neurol

28. POLI M, Bonomi CG, Di Donna MG, Barberis I, et al
    Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Abeta42 ratios.
    J Neurol. 2026;273:306.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

29. KOSIK KS
    Genetic modifiers in autosomal dominant Alzheimer's disease.
    Lancet Neurol. 2026;25:537-538.
    PubMed        
    
    
30. PATEL M, Feng W, Mckay NS, Millar PR, et al
    Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study.
    Lancet Neurol. 2026;25:581-590.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

31. STEPANCHUK AA, Joseph JT, Lashley T, Stys PK, et al
    Disentangling amyloid polymorphs in normal aging and Alzheimer's disease using dual-probe spectral imaging.
    Neurobiol Aging. 2026;165:51-59.
    PubMed         Abstract available
    
    
32. FARACI G, Goodfriend B, Bishop J, Vu M, et al
    The TREM2 R47H variant is associated with liver-plasma-brain axis dyshomeostasis in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Aging. 2026;165:24-37.
    PubMed         Abstract available
    
    
33. COLES M, Rosa Porto R, Chesworth R, Steiner-Lim GZ, et al
    Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio - a new therapeutic strategy for APP(Swe)/PS1DeltaE9 transgenic mice?
    Neurobiol Aging. 2026;164:79-90.
    PubMed         Abstract available
    
    
34. BERCOVITCH R, Tio ES, Wickramatunga R, Misztal M, et al
    Genetic predisposition to hand grip strength predicts cognitive decline.
    Neurobiol Aging. 2026;164:28-38.
    PubMed         Abstract available
    
    
35. CHU TDX, Hui LM, Khatri N, Jean Chen J, et al
    Resilience to mid-to-late-life depression as a risk factor for Alzheimer's disease: Physiological factors and the role of neuroimaging.
    Neurobiol Aging. 2026;166:1-13.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

36. PERL AT, Wu J, Dong JD, Brooks AM, et al
    Immune receptor LAG3 regulates microglia function during Alzheimer's disease.
    Neurobiol Dis. 2026 May 11:107447. doi: 10.1016/j.nbd.2026.107447.
    PubMed         Abstract available
    
    

    
    Neurochem Res

37. ZHOU B, Wu X, Wang J, Li L, et al
    Compatibility of Acorus tatarinowii Schott and Polygala tenuifolia Willd. alleviate Alzheimer's disease through regulating Nos2-mediated calcium signaling pathway.
    Neurochem Res. 2026;51:153.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

38. ATRI A, Apostolova LG, Iwata A, Wessels AM, et al
    Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial.
    Neurol Clin Pract. 2026;16:e200621.
    PubMed         Abstract available
    
    

    
    Neuroscience

39. GUO M, Zou Y, Wang T, Wu H, et al
    Spatiotemporal reconfiguration of functional networks by transcranial magnetic stimulation in Alzheimer's disease.
    Neuroscience. 2026 May 7:S0306-4522(26)00305.
    PubMed         Abstract available
    
    

    
    PLoS One

40. 
    Retraction: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    PLoS One. 2026;21:e0349363.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum